Physician profile
Daniel W Simon
NPI 1013997428
$43,072.14
in general payments reported to CMS, 2019-2025
27 companies · $7,526 in 2025
The $7,526 reported for 2025 was more than what 88% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,206 · 2021: $3,074 · 2022: $2,059 · 2023: $7,955 · 2024: $6,050 · 2025: $7,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Consulting Fee: $4,300 · Food and Beverage: $2,498 · Travel and Lodging: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $14,130.01 |
| Consulting Fee | $4,300.00 |
| Food and Beverage | $2,498.09 |
| Travel and Lodging | $603.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $14,482.30 | 2021-2025 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Terumo Medical Corporation | $13,914.40 | 2019-2024 | Navicross |
| Cordis US Corp. | $4,756.44 | 2021-2023 | Saber, Brite Tip Radianz |
| Philips North America LLC | $3,010.26 | 2019-2025 | IV Other, (P84) Igt Devices Systems, Peripheral Vascular Undivided |
| Siemens Medical Solutions USA, INC. | $2,009.26 | 2019 | |
| Boston Scientific Corporation | $1,262.81 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Enroute Transcarotid Neuroprotection System, Watchman Flx |
| Abbott Laboratories | $823.44 | 2019-2025 | Diamondback Peripheral, Absolute Pro, Esprit |
| Nevro Corp. | $768.59 | 2024 | Senza |
| Bard Peripheral Vascular, INC. | $378.32 | 2020-2025 | Covera, Lifestar Biliary Stent |
| Cardiovascular Systems INC. | $326.99 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $241.15 | 2021-2022 | |
| Medtronic, INC. | $210.67 | 2024 | Concertotm, Closurefast |
| Resmed Corp | $145.20 | 2023 | |
| Cardinal Health 200 LLC | $130.24 | 2019 | |
| Vasorum USA INC. | $114.96 | 2023 | Celt Acd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $107.03 | 2025 | Indigo System |
| Cook Medical LLC | $69.35 | 2020-2022 | |
| Cagent Vascular INC | $68.23 | 2024 | Serrantor |
| Novartis Pharmaceuticals Corporation | $57.28 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $40.84 | 2019 | |
| Atricure, INC. | $31.22 | 2021 | |
| Organogenesis INC. | $27.01 | 2023 | Puraply |
| Veryan Medical Incorporated | $25.56 | 2022 | |
| Novo Nordisk INC | $23.84 | 2022 | |
| Biotronik INC. | $19.07 | 2022 | |
| Merck Sharp & Dohme LLC | $15.53 | 2021 | |
| Gilead Sciences, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.